JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jan van der Linden
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Linden, J.
Right arrow Articles by Dellgren, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Linden, J.
Right arrow Articles by Dellgren, G.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Transplantation - heart

J Thorac Cardiovasc Surg 2002;124:641-642
© 2002 The American Association for Thoracic Surgery

Letters to the Editor

Megadose of milrinone as an alternative to extracorporeal membrane oxygenation for treatment of graft failure early after cardiac transplantation

Jan van der Linden, MD, Anders Albåge, MD, Göran Dellgren, MD

Department of Cardiothoracic Surgery and Anaesthesiology, Karolinska Institute, Huddinge University Hospital, SE-141 86 Stockholm, Sweden

The first 20% of the full text of this article appears below.

To the Editor:

Extracorporeal membrane oxygenation (ECMO) has been suggested as a successful rescue intervention in primary allograft failure.Go 1 Taghavi and coworkers reported their experience of 6 patients supported by ECMO because of right or biventricular failure after cardiac transplantation. Five patients were successfully weaned from ECMO, but 2 of these died of sepsis-induced multiorgan failure. All patients were in cardiac failure before initiation of ECMO despite maximal drug treatment, which in their institution included high doses of norepinephrine and suprarenin. They also discussed the possibilities of . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.